))
Ten CMC Questions for Emerging Biotechs in 2025
Manage episode 456268858 series 3603634
Content provided by Despina & Ethan at Enkrisi and Ethan at Enkrisi. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Despina & Ethan at Enkrisi and Ethan at Enkrisi or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
This podcast presents ten crucial questions for emerging biotech companies to consider when reviewing their Chemistry, Manufacturing, and Controls (CMC) strategies at year-end. The questions cover various aspects, including regulatory milestones, data analytics, risk management, quality assurance, and future goals. Each question includes examples illustrating its importance for successful drug development. The ultimate aim is to ensure a robust CMC strategy aligned with regulatory expectations and industry best practices, thereby minimizing delays and maximizing the chances of successful submissions. Failing to address these questions could result in significant setbacks.
24 episodes
Share
